Parathyroid hormone status does not influence blood and bone lead levels in dialysis patients

American Journal of the Medical Sciences

Volumn 334, Issue 6, 2007, Pages 415-420

  Ghosh Narang, Jhumka ^a   Jones, Tiffany M ^b   Menke, Andy ^c   Todd, Andrew C ^d   Muntner, Paul ^a,b   Batuman, Vecihi ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Bone lead; Dialysis; End stage kidney disease; Uremic bone disease; X ray fluorescence

Indexed keywords

ALBUMIN; CADMIUM 109; CALCIUM; LEAD; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; BONE LEVEL; BONE TURNOVER; CALCIUM BLOOD LEVEL; CIGARETTE SMOKING; EDUCATIONAL STATUS; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INTERVIEW; KIDNEY FAILURE; LEAD BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; QUESTIONNAIRE; SEX DIFFERENCE; TIBIA; UREMIA; X RAY FLUORESCENCE;

ADULT; AFRICAN AMERICANS; BONE AND BONES; BONE REMODELING; CALCIUM; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; LEAD; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHORUS; RENAL DIALYSIS; SERUM ALBUMIN; SEX FACTORS; TIBIA;

EID: 37349120465     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e318068b237     Document Type: Article

References (27)

1. Menke A, Muntner P, Batuman V, et al. Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. Circulation 2006;114:1388-94.
2. Muntner P, Menke A, DeSalvo KB, et al. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Arch Intern Med 2005;165:2155-61.
3. Vupputuri S, He J, Muntner P, et al. Blood lead level is associated with elevated blood pressure in blacks. Hypertension 2003;41:463-8.
4. Muntner P, He J, Vupputuri S, et al. Blood lead and chronic kidney disease in the general United States population: results from NHANES III. Kidney Int 2003;63:1044-50.
5. Brewster UC, Perazella MA. A review of chronic lead intoxication: an unrecognized cause of chronic kidney disease. Am J Med Sci 2004;327:341-7.
6. Emmerson BT. Chronic lead nephropathy. Kidney Int 1973;4:1-5.
7. Batuman V, Landy E, Maesaka JK, et al. Contribution of lead to hypertension with renal impairment. N Engl J Med 1983;309:17-21.
8. Batuman V. Lead nephropathy, gout, and hypertension. Am J Med Sci 1993;305:241-7.
9. Lin JL, Ho HH, Yu CC. Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency: a randomized, controlled trial. Ann Intern Med 1999;130:7-13.
10. Loghman-Adham M. Renal effects of environmental and occupational lead exposure. Environ Health Perspect 1997;105:928-39.
11. Staessen JA, Lauwerys RR, Buchet JP, et al. Impairment of renal function with increasing blood lead concentrations in the general population: the Cadmibel Study Group. N Engl J Med 1992;327:151-6.
12. Emmerson BT. Lead stores in patients with renal insufficiency. Nephron 1991;58:233-4.
13. Wedeen RP, Van de Vyver FL, D'Haese PC, et al. Bone lead and the diagnosis of lead nephropathy. Contrib Nephrol 1988;64:102-8.
14. Van de Vyver FL, D'Haese PC, Visser WJ, et al. Bone lead in dialysis patients. Kidney Int 1988;33:601-7.
15. Todd AC. Coherent scattering and matrix correction in bonelead measurements. Phys Med Biol 2000;45:1953-63.
16. Todd AC. Calculating bone-lead measurement variance. Environ Health Perspect 2000;108:383-6.
17. Todd AC. Contamination of in vivo bone-lead measurements. Phys Med Biol 2000;45:229-40.
18. Todd AC. Calculating bone-lead measurement variance: printer's correction. Environ Health Perspect 2000;108:A298.
19. Todd AC, Ehrlich RI, Selby P, et al. Repeatability of tibia lead measurement by x-ray fluorescence in a battery-making workforce. Environ Res 2000;84:282-9.
20. Todd AC, McNeill FE. In vivo measurement of lead in bone using a 109 Cd "spot" source. In: Ellis KJ, Eastman JD, Human Body Composition Studies. New York, Plenum Press, 1993: pp 299-302.
21. Todd AC, Parsons PJ, Carroll S, et al. Measurements of lead in human tibiae: a comparison between K-shell x-ray fluorescence and electrothermal atomic absorption spectrometry. Phys Med Biol 2002;47:673-87.
22. Khalil-Manesh F, Tartaglia-Erler J, Gonick HC. Experimental model of lead nephropathy, IV: correlation between renal functional changes and hematological indices of lead toxicity. J Trace Elem Electrolytes Health Dis 1994;8:13-9.
23. Bushinsky DA, Monk RD. Electrolyte quintet: calcium. Lancet 1998;352:306-11.
24. 2003 annual report: ESRD clinical performance measures project. Am J Kidney Dis 2004;44:A5-6, S1-92.
25. Osterloh JD. Observations on the effect of parathyroid hormone on environmental blood lead concentrations in humans. Environ Res 1991;54:8-16.
26. Osterloh JD, Clark OH. Effects of hyperparathyroidism on blood lead concentrations in man. Environ Res 1993;62:1-6.
27. Osterode W, Winker R, Bieglmayer C, et al. Effects of parathyroidectomy on lead mobilization from bone in patients with primary hyperparathyroidism. Bone 2004;35:942-7.